Table 1.
Gonçalves Dias | Mal-ED Birth | Mal-ED Case Control | Recodisa Case Control | PU Zinc-Arginine Trial | PU Zinc Vitamin A Trial | Total | |
---|---|---|---|---|---|---|---|
Study Typea | Birth Cohort | Birth Cohort | Prospective Case-Control | Prospective Case-Control | Randomized Clinical Trial | Randomized Clinical Trial | |
Location | Fortaleza, Gonçalves Dias Favela | Fortaleza | Fortaleza, IPREDE | 6 Cities in 4 North-Eastern States | Fortaleza, Parque Universitário | Fortaleza, Parque Universitário | |
Enrollment | 1989–1993 | 2010–2014 | 2010–2014 | 2010–2014 | 2006–2010 | 2000–2006 | |
Samples Genotyped | 172 | 300 | 368 | 1044 | 126 | 109 | 2,119 |
Samples Post-Genotyping QC | 110 | 276 | 336 | 658 | 95 | 63 | 1,538 |
SNP QCb | All Cohorts: SNPs | ||||||
Total SNPs on Affymetrix Axiom LAT-1 Array 4 | 818,154 | ||||||
Affymetrix SNP QC: SNPs dropped | 62,353 | ||||||
SNPs Remaining | 755,801 | ||||||
Call Rate < 99% + MAFc < 5% | −345,629 | ||||||
SNPS Remaining | 410,172 |
The top half of the table shows the number of DNA samples genotyped by study and the number remaining after genome-wide genotyping QC.
The bottom half of the table shows the initial total number of SNPs on the Affymetrix array used and the number remaining after QC. The same SNP results pertain to all studies and are only shown once for clarity.
MAF: Minor Allele Frequency.